Recent selling Puzzled as to the weakness of the stock right now as irrespective of NMIBC there should be strong hope value in the pre-clinical progress of TLD-1433 in NSCLC at Roswell Park and Rutherrin for GBM in Toronto.
Might this have to do with the IP ownership of Sherri`s super compounds as referred to in the ann below?
https://web.tmxmoney.com/article.php?newsid=5063081139073863&qm_symbol=TLT
We are left guessing but the volume of selling at this low price - below the level at which warrants retained from the last raise would give a profit - is unsettling and the current silence reminiscent of the long pause in the middle of Phase 1B which we were only later told co-incided with a need to re-calibrate the treatment.
Shareholders deserve an update - good or bad - and it is a pathetic excuse to hide behind Covid as a reason not to provide one.